What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease Control and Prevention stand up to her boss? And can Amgen overcome its obesity drug’s side effects?
We discuss all that and more on this on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.
We invite STAT’s senior writer for infectious diseases, Helen Branswell, and Washington correspondent Chelsea Cirruzzo on to the podcast to discuss the latest news at the CDC. The agency is in the spotlight once again, after the Senate grilled the potential head of the agency at a confirmation hearing and its federal vaccine advisory committee met for the first time after Robert F. Kennedy Jr. fired its existing 17 members and installed a new, smaller panel.
We also discuss the latest news in the life sciences, including data presented at last weekend’s American Diabetes Association research meeting. We also squeeze in some conversation about summer blockbusters. (Check out Adam’s “Jaws” Lego set here).
To read about how vaccine policy is fracturing, go here; for more on CDC nominee Susan Monarez’s confirmation hearing, go here; for the latest on Amgen’s MariTide data, go here; and for the details on Vertex’s diabetes cell therapy, go here.
Be sure to sign up for “The Readout LOUD” on Apple Podcasts, Spotify, or wherever you get your podcasts.
